AAAAAA
Results: 1-25/31
Authors:
HEBERTCROTEAU N
BRISSON J
LATREILLE J
GARIEPY G
Citation: N. Hebertcroteau et al., TIME TRENDS IN SYSTEMIC ADJUVANT TREATMENT OF EARLY-STAGE NODE-NEGATIVE BREAST-CANCER IN QUEBEC, European journal of cancer, 34, 1998, pp. 5-5
Authors:
RIVIERE M
LATREILLE J
FALARDEAU P
DUPONT E
Citation: M. Riviere et al., AE-941 (NEOVASTAT), AN INHIBITOR OF ANGIOGENESIS - PHASE I II LUNG-CANCER CLINICAL-TRIAL RESULTS/, Annals of oncology, 9, 1998, pp. 636-636
Authors:
LATREILLE J
GELMON K
EISENHAUER E
TOLCHER A
FISHER B
VERNILLET L
DAIGNEAULT L
HOSTETLERYANOWITZ C
LEBECQ A
BESENVAL M
Citation: J. Latreille et al., PHASE-I TRIAL OF THE NEW TAXOID RPR 109881A IN A DAY 1 AND 8 INTRAVENOUS (IV) SCHEDULE EVERY 3 WEEKS - AN NCI CANADA CLINICAL-TRIALS GROUP-STUDY, Annals of oncology, 9, 1998, pp. 382-382
Authors:
LEBECQ A
DIERAS V
MARTY M
SESSA C
PAZDUR R
GELMON K
LATREILLE J
EISENHAUER E
BESENVAL M
RIVA A
DURRLEMAN S
Citation: A. Lebecq et al., PRELIMINARY EVALUATION OF THE MODIFIED CONTINUAL REASSESSMENT METHOD (MCRM) IN 4 PHASE-I STUDIES WITH RPR109881A, Annals of oncology, 9, 1998, pp. 488-488
Authors:
GINSBURG AD
LEVINE MN
BOWMAN DM
OLIVOTTO IA
FIELDS LA
LITTLE CD
CANTIN J
MCGREGOR M
GOLDHIRSCH A
BRAMWELL V
GELMON K
BRYCE C
ALLAN S
NORRIS B
LATREILLE J
PATERSON ADH
TOMIAK E
TREMBLAY G
BAIRD R
BECKER P
BUTTS C
DANCEY JT
GOEL R
KVERN B
MILNE C
NAROD S
NOLAN E
THURLOW WH
WONG R
Citation: Ad. Ginsburg et al., ADJUVANT SYSTEMIC THERAPY FOR WOMEN WITH NODE-NEGATIVE BREAST-CANCER, CMAJ. Canadian Medical Association journal, 158, 1998, pp. 43-51
Authors:
LATREILLE J
PATER J
JOHNSTON D
LABERGE F
STEWART D
RUSTHOVEN J
HOSKINS P
FINDLAY B
MCMURTRIE E
YELLE L
WILLIAMS C
WALDE D
ERNST S
DHALIWAL H
WARR D
SHEPHERD F
MEE D
NISHIMURA L
OSOBA D
ZEE B
Citation: J. Latreille et al., USE OF DEXAMETHASONE AND GRANISETRON IN THE CONTROL OF DELAYED EMESISFOR PATIENTS WHO RECEIVE HIGHLY EMETOGENIC CHEMOTHERAPY, Journal of clinical oncology, 16(3), 1998, pp. 1174-1178
Authors:
HEBERTCROTEAU N
BRISSON J
LATREILLE J
BLANCHETTE C
DESCHENES L
Citation: N. Hebertcroteau et al., AGE-RELATED VARIATIONS IN MANAGEMENT OF NODE-NEGATIVE BREAST-CANCER, American journal of epidemiology, 147(11), 1998, pp. 300-300
Authors:
DANCEY J
ZEE B
OSOBA D
WHITEHEAD M
LU F
KAIZER L
LATREILLE J
PATER JL
Citation: J. Dancey et al., QUALITY-OF-LIFE SCORES - AN INDEPENDENT PROGNOSTIC VARIABLE IN A GENERAL-POPULATION OF CANCER-PATIENTS RECEIVING CHEMOTHERAPY, Quality of life research, 6(2), 1997, pp. 151-158
Authors:
OSOBA D
ZEE B
WARR D
LATREILLE J
KAIZER L
PATER J
Citation: D. Osoba et al., EFFECT OF POSTCHEMOTHERAPY NAUSEA AND VOMITING ON HEALTH-RELATED QUALITY-OF-LIFE, Supportive care in cancer, 5(4), 1997, pp. 307-313
Authors:
OSOBA D
ZEE B
PATER J
WARR D
LATREILLE J
KAIZER L
Citation: D. Osoba et al., DETERMINANTS OF POSTCHEMOTHERAPY NAUSEA AND VOMITING IN PATIENTS WITHCANCER, Journal of clinical oncology, 15(1), 1997, pp. 116-123
Authors:
GHADIRIAN P
JEANNERET A
PERRET C
LATREILLE J
AYOUB J
SANDERSON D
Citation: P. Ghadirian et al., CARCINOMA OF THE LUNG IN 3 BROTHERS AND 2 SISTERS, Lung cancer, 18(3), 1997, pp. 259-264
SPACE-TIME ANALYSIS OF THE INCIDENCE OF C ANCER IN CERTAIN SITES OF QUEBEC - 1984-1986 AND 1989-1991
Authors:
THOUEZ JP
EMARD JF
BEAUPRE M
LATREILLE J
GHADIRIAN P
Citation: Jp. Thouez et al., SPACE-TIME ANALYSIS OF THE INCIDENCE OF C ANCER IN CERTAIN SITES OF QUEBEC - 1984-1986 AND 1989-1991, Canadian journal of public health, 88(1), 1997, pp. 48-51
Authors:
SHEPHERD FA
LATREILLE J
CRUMP M
STEWART D
TOMIAK E
EISENHAUER E
FISHER B
Citation: Fa. Shepherd et al., PHASE-I STUDY OF PACLITAXEL (TAXOL(TM)) AND IFOSFAMIDE IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER - A STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP, Annals of oncology, 7(3), 1996, pp. 311-313
Authors:
BRADBURY J
BRYANT H
CASEBOLT T
LATREILLE J
PAWELEK J
OLIVOTTO I
Citation: J. Bradbury et al., A CANADIAN EXPERIMENT WITH BREAST-CANCER INFORMATION EXCHANGE PILOT PROJECTS, Patient education and counseling, 28(2), 1996, pp. 169-174
Authors:
CONTE PF
LATREILLE J
MAURIAC L
CALABRESI F
SANTOS R
CAMPOS D
BONNETERRE J
FRANCINI G
FORD JM
Citation: Pf. Conte et al., DELAY IN PROGRESSION OF BONE METASTASES IN BREAST-CANCER PATIENTS TREATED WITH INTRAVENOUS PAMIDRONATE - RESULTS FROM A MULTINATIONAL RANDOMIZED CONTROLLED TRIAL, Journal of clinical oncology, 14(9), 1996, pp. 2552-2559
Authors:
RUSTHOVEN JJ
QUIRT IC
ISCOE NA
MCCULLOCH PB
JAMES KW
LOHMANN RC
JENSEN J
BURDETTERADOUX S
BODURTHA AJ
SILVER HKB
VERMA S
ARMITAGE GR
ZEE B
BENNETT K
HEDLEY D
FINE S
MYERS R
KING M
MERTENS W
TAYLOR M
CANO P
MALIK S
VERGIDIS D
SHORE S
DUDGEON D
SMYLIE M
WILSON K
KNOWLING M
SAMOSH M
GIESBRECHT J
HUAN S
SKILLINGS J
GREGG R
BELANGER K
POLLAK M
LATREILLE J
BATIST G
BOOS G
GRUNER P
HINGS I
LOUTFI A
THIRLWELL M
TRUDEAU M
JOLIVIT J
AYOUB J
CHARPENTIER D
CLEMENT S
YELLE L
BELANGER D
SHIBATA H
Citation: Jj. Rusthoven et al., RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL COMPARING THE RESPONSE RATES OF CARMUSTINE, DACARBAZINE, AND CISPLATIN WITH AND WITHOUT TAMOXIFEN IN PATIENTS WITH METASTATIC MELANOMA, Journal of clinical oncology, 14(7), 1996, pp. 2083-2090
Authors:
SHEPHERD FA
LATREILLE J
PAUL K
EISENHAUER E
Citation: Fa. Shepherd et al., PHASE-I DOSE-ESCALATION TRIAL OF PACLITAXEL AND IFOSFAMIDE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 23(6), 1996, pp. 84-90
Authors:
OSOBA D
ZEE B
WARR D
KAIZER L
LATREILLE J
PATER J
Citation: D. Osoba et al., QUALITY-OF-LIFE STUDIES IN CHEMOTHERAPY-INDUCED EMESIS, Oncology, 53, 1996, pp. 92-95
Authors:
LATREILLE J
LABERGE F
VIALLET J
MAKSYMIUK A
SHEPHERD F
GELMAN K
DELORME F
Citation: J. Latreille et al., PHASE-II TRIAL WITH DOCETAXEL IN PATIENTS (PTS) WITH NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 31A, 1995, pp. 1070-1070
Authors:
JOHNSTON D
LATREILLE J
LABERGE F
STEWART D
RUSTHOVEN J
FINDLAY B
ERNST S
WILLIAMS CKO
HOSKINS P
YELLE L
MCMURTRIE E
DHALIWAL H
NISHIMURA L
PATER J
ZEE B
Citation: D. Johnston et al., PREVENTING NAUSEA AND VOMITING DURING DAYS 2-7 FOLLOWING HIGH-DOSE CISPLATIN CHEMOTHERAPY (HDCP), European journal of cancer, 31A, 1995, pp. 1204-1204
Authors:
GHADIRIAN P
NAROD S
PERRET C
LAMBERT DM
LATREILLE J
LETENDRE F
MONTE M
BELANGER D
Citation: P. Ghadirian et al., HEREDITARY BREAST-CANCER IN 19 FEMALES AND 2 MALES - PG,KINDRED 1940, European journal of cancer, 31A(2), 1995, pp. 284-287
Authors:
LATREILLE J
STEWART D
LABERGE F
HOSKINS P
RUSTHOVEN J
MCMURTRIE E
WARR D
YELLE L
WALDE D
SHEPHERD F
DHALIWAL H
FINDLAY B
MEE D
PATER J
ZEE B
JOHNSTON D
Citation: J. Latreille et al., DEXAMETHASONE IMPROVES THE EFFICACY OF GRANISETRON IN THE FIRST 24 H FOLLOWING HIGH-DOSE CISPLATIN CHEMOTHERAPY, Supportive care in cancer, 3(5), 1995, pp. 307-312
Authors:
MIGNAULT GG
LATREILLE J
VIGUIE F
RICHER P
LEMIRE F
HARSANYI Z
STEWART JH
Citation: Gg. Mignault et al., CONTROL OF CANCER-RELATED PAIN WITH MS CONTIN(R) - A COMPARISON BETWEEN 12-HOURLY AND AND 8-HOURLY ADMINISTRATION, Journal of pain and symptom management, 10(6), 1995, pp. 416-422
Authors:
LATREILLE J
CORMIER Y
MARTINS H
GOSS G
FISHER B
EISENHAUER EA
Citation: J. Latreille et al., PHASE-II STUDY OF DOCETAXEL (TAXOTERE) IN PATIENTS WITH PREVIOUSLY UNTREATED EXTENSIVE SMALL-CELL LUNG-CANCER - A TRIAL OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP (NCIC CTG), Investigational new drugs, 13(4), 1995, pp. 343-345
Authors:
LATREILLE J
Citation: J. Latreille, THE ROLE OF DOCETAXEL (TAXOTERE) IN THE MANAGEMENT OF BREAST-CANCER -A SUMMARY, Seminars in oncology, 22(6), 1995, pp. 1-2